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osting by EAbstract Fetal arrhythmias are detected in at least 2% of unselected pregnancies during routine
obstetrical scans. Most common are transient, brief episodes of a slow or fast heart rate or of an
irregular heart rhythm. Less common are prolonged or persistent abnormalities such as supraven-
tricular tachycardia and complete heart block which may lead to low cardiac output, fetal hydrops
and demise. The objectives of this review are to update the reader on the diagnosis and management
of the more common arrhythmias.
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lsevier1. Introduction
The cardiac conduction system is composed of highly special-
ized tissue that is able to rhythmically generate electrical im-
pulses in the sinus node and to propagate the electrical
current across the atriums, the AV-node and the His-Purkinje
system throughout the ventricles. Synchronized depolarization
and repolarization of atrial and ventricular myocardial tissue
result in rhythmic contraction and relaxation of these cavities,
Figure 1b Example of a normal Doppler tracing obtained by
simultaneous pulse wave Doppler of the aorta and the SVC. The
Doppler sample volume is simultaneously placed within the aorta
and the SVC.
62 R. Weber et al.allowing the coordinated ﬁlling and emptying of the heart dur-
ing each cardiac cycle. Depending on the level of fetal activity,
the typical fetal heart rate ranges between 120 and 180 beats
per minute (bpm) with little beat-to-beat variation. Fetal
arrhythmia may be deﬁned as an irregularity of the cardiac
rhythm, as an abnormally slow (<100 bpm) or fast
(>180 bpm) heart rate, or as a combination of irregular
rhythm and abnormal heart rate. Fetal arrhythmias are de-
tected in at least 2% of unselected pregnancies during routine
obstetrical scans and are a common reason for referral to the
fetal cardiologist. The goal of this review is to discuss the diag-
nosis, clinical manifestation and management of the most com-
mon fetal rhythm abnormalities.
2. Echocardiographic assessment of the fetal heart rhythm
After birth, the etiological classiﬁcation of a newly detected
cardiac arrhythmia relies primarily on characteristic electro-
cardiographic ﬁndings including the rate, morphology and
chronology of atrial and ventricular electrical events. In the fe-
tus, the assessment of arrhythmias becomes more challenging
as conventional real-time electrocardiogram (ECG) is not ob-
tained. Fetal ECG and fetal magnetocardiography are only
available in a few centers world-wide and are mainly used as
research tools. Alternatively, fetal M-mode and Doppler echo-
cardiography can be used to study the rate and timing of atrial
and ventricular mechanical events which occur brieﬂy after
their respective electrical depolarization (Jaeggi et al., 1998a;
Fouron et al., 2000; Rein et al., 2002). Fetal echocardiography
does not inform about the morphology of electrical complexes
(e.g. P-wave axis) nor on QRS- and QT-interval durations. De-
spite these limitations, with some ultrasound experience and a
basic understanding of electrophysiological principles, it is al-
most always possible to correctly identify the arrhythmia
mechanism based on characteristic echocardiographic pattern
(Jaeggi et al., 1998a; Fouron et al., 2003; Fouron, 2004).
Figs. 1a and 1b show examples of M-mode and pulsed-
wave Doppler recordings of a normal fetal cardiac rhythm.
To record sequences of atrial and ventricular events by myo-
cardial M-mode imaging it is important to align the M-mode
cursor simultaneously through the atrial and ventricular walls.Figure 1a M-mode tracing using a four-chamber view to
demonstrate atrial (A) and ventricular (V) wall motions. The M-
mode beam is directed through the left atrium (LA) and right
ventricle (RV).The preferred M-mode beam direction is e.g. in the cardiac 4-
chamber view simultaneously through the atrial free wall and
the opposite ventricular free wall close to the AV junction be-
cause these parts show the most pronounced lateral excursion
during the cardiac cycle. This approach is particularly relevant
to assess hearts with reduced wall motion. A main limitation of
M-mode is that mechanical events are not well-deﬁned on M-
mode recordings. Therefore, it may not be possible to achieve
precise measurements of time intervals between mechanical
events. Doppler ﬂow signals are far better delineated which
makes Doppler echocardiography a superior modality for
the assessment of the fetal cardiac rhythm and AV-conduction.
Simultaneous recording of the vena cava superior (SVC) and
the ascending aorta Doppler ﬂow is a particularly useful imag-
ing tool for the detailed assessment of any arrhythmia. Ana-
tomically the SVC and aorta are closely-related. This is best
illustrated in the sagittal plane by 2-dimensional echocardiog-
raphy. By placing the Doppler sample volume simultaneously
within both vessels it becomes possible to concurrently record
their blood ﬂow patterns. The normal SVC ﬂow consists of
three ﬂow waves which are the larger S and D waves that
are directed towards the heart during ventricular systole
(S-wave) and in early diastole (D-wave) followed by a brief ret-
rograde a-wave. The a-wave is explained by intermittent ﬂow
reversal into the vena cava at the time the atrium contracts
(atrial systole) which is immediately after atrial depolarization.
The a-wave can therefore be considered as the mechanical
equivalent of the electrocardiographic P-wave. The aortic ejec-
tion ﬂow from the ascending aorta Doppler correlates with
ventricular systolic contraction that follows electrical ventricu-
lar depolarization which corresponds to the electrocardio-
graphic QRS complex. Using SVC-aorta Doppler, the timing
between atrial and ventricular events can therefore be mea-
sured from the onset of the venous a-wave (A) to the onset
of the ascending aorta ﬂow (V) and then compared to
published reference data. Despite differences in delay between
electrical and mechanical activation of atriums and ventricles,
there is a good correlation between echocardiographic AV-
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AV-intervals physiologically prolong with advancing fetal
age (Andelﬁnger et al., 2001; Nii et al., 2006).
As previously mentioned, the normal fetal heart beats reg-
ularly somewhere between 120 and 160 bpm. Each atrial event
is followed by a ventricular event which occurs within a well-
deﬁned time-interval (normal 1:1 AV conduction). By means
of echocardiography it is possible to accurately differentiate
most fetal arrhythmias. To be able to do this it is crucial: (1)
to obtain good quality M-mode or Doppler recordings to iden-
tify atrial and ventricular events; (2) to systematically analyze
the regularity and rate of atrial–atrial (A–A) and ventricular–
ventricular (V–V) events and to determine the relation between
atrial and ventricular beats (AV-chronology; AV-conduction
ratio); and, (3) to examine the impact of the arrhythmia on fe-
tal well-being. Major arrhythmias that result in persistently
faster or slower heart rates may be associated with poor ven-
tricular function and fetal hydrops. Moreover, there is a strong
association between some types of fetal arrhythmias and struc-
tural heart disease for which the fetus should also be examined
by detailed echocardiography.
3. Irregular rhythm
Irregularities of the cardiac rhythm belong to the most com-
mon rhythm anomalies at any age. In the fetus this ﬁnding is
almost always associated with isolated premature atrial con-
tractions (PACs). PACs are explained by atrial cells that elec-
trically ﬁre before the normal atrial beat is to occur which
resets the normal sinus beat. Depending on the degree of pre-
maturity of the ectopic event, a PAC may be conducted to the
ventricles or be blocked within the AV node and thus manifest
either as extra beat or as missed beat on auscultation or ultra-
sound examination (Fig. 2). Frequently blocked PACs will re-
sult in a markedly irregular cardiac rhythm with slowing of the
average heart rate. If every 2 beat is a non-conducted PACs
(atrial bigeminy) this will result in a regular bradyarrhythmiaFigure 2 Conducted PAC. M-Mode tracing from a four
chamber view with the transducer beam through the RA and the
RV. There is a conducted PAC followed by an early ventricular
contraction (V).between 60 and 80 beats/min and needs to be differentiated
from more serious causes of fetal bradycardia such as complete
heart block (see below). Irrespective of whether PACs are con-
ducted or blocked and are frequent or rare, they are usually
well-tolerated and resolve spontaneously with no need of treat-
ment. In rare cases, nevertheless, progression to supraventric-
ular tachycardia is possible. Therefore, intermittent heart
rate monitoring (e.g. once per week for the next 2–3 weeks
by the obstetrician) is recommended to exclude the develop-
ment of a major tachyarrhythmia. PACs have also been asso-
ciated with structural heart disease in up to 2% of cases,
intracardiac tumors and redundancy of the atrial septum
which are detectable by echocardiography. Premature ventric-
ular contractions (PVCs) are an uncommon, usually benign
cause of an intermittently irregular heart rhythm in the fetus.
Still, serial echocardiographic assessment is advised as PVCs
have been associated with myocarditis and long QT syndrome.
Treatment for isolated PVCs is not required.
4. Fetal bradycardia
Fetal bradycardia is conventionally deﬁned by a decrease in
heart rate <100 bpm although a heart rate persistently slower
than 120 beats/min is not a normal ﬁnding. Brief heart rate
deceleration of less than 1–2 min is common and, in general,
without clinical relevance. More concerning is the observation
of sustained bradycardia which typically relates to one of the
following mechanisms: (1) sinus bradycardia; (2) atrial bigem-
iny; and, (3) complete heart block (CHB).
Sinus bradycardia secondary to advanced fetal hypoxia is an
obstetrical emergency: survival depends on expedited delivery.
Cardiac etiologies of sinus bradycardia are less common but
include long QT-syndrome due to extremely prolonged repo-
larization and the congenital absence or dysfunction of the si-
nus node e.g. in left isomerism of the atrial appendage (Ho
et al., 1995). The cardiac causes are distinguished based on
tell-tale echocardiographic and postnatal electrocardiographic
ﬁndings.
Multiple non-conducted PACs may result in an irregular,
slow ventricular rate below 100 bpm. The heart rate becomes
regular if every second beat is a blocked PAC which deﬁnesFigure 3 Blocked PAC. M-Mode tracing from a four chamber
view with the transducer beam through the RA and the RV. There
are blocked PAC’s in a trigeminy pattern. Only the normal atrial
contractions (A) are followed by a ventricular contraction (V).
Figure 4a Complete heart block. M-Mode tracing from a four
chamber view with the transducer beam through the RA and the
LV. There are regular atrial contractions (A) with a normal heart
rate of 125 bpm and independent ventricular contractions (V) with
a heart rate of 50 bpm.
Figure 4b Simultaneous pulse wave Doppler of the aorta and
vena cava superior of a fetus with complete heart block showing
backﬂow following atrial contractions (A) in the superior vena
cava with an atrial rate of 140/min (A) and in the same direction
aortic outﬂow following ventricular contractions (V) which are
independent with a regular rate of 60/min.
64 R. Weber et al.non-conducted atrial bigeminy (Fig. 3). On the M-mode or
Doppler recording of atrial bigeminy, the atrial rate is irregular
(alternating sinus and premature beats) while the ventricles
beat at a regularly slow pace (60–80 bpm) that is half of the at-
rial rate. Atrial bigeminy may persist for hours but is clinically
benign and ultimately will resolve without treatment.
Irreversible complete heart block, the most common fetal
presentation of a conduction disorder, accounts for almost half
of all major fetal arrhythmias seen by Fetal Cardiology. On
echocardiography, the atrial rate is normal and regular but
the ventricles beat independently at a much slower rate (40–
80 bpm) due to the failure of electrical AV conduction
(Fig. 4). Heart block is most commonly associated either with
structural heart disease or with maternal anti-Ro autoantibod-ies. The condition carries a signiﬁcant mortality risk as the fe-
tus needs to overcome the slow ventricular rate, the loss of
coordinated atrial contribution to ventricular ﬁlling, and per-
haps concomitant heart disease or carditis. The detection of
a major structural heart disease, fetal hydrops, poor contractil-
ity, and ventricular rates below 50 bpm are all associated with
a poor pregnancy outcome.
The most common association of fetal CHB with structural
heart disease is unbalanced atrioventricular septal defect asso-
ciated with left isomerism, which is almost universally lethal,
independent of the choice of perinatal care. Fetal CHB with-
out structural heart disease has a better prognosis and is
mainly related to the transplacental passage of maternal auto-
antibodies directed to fetal Ro/SSA ribonucleoproteins. Anti-
Ro antibodies are present in about 2% of pregnant women.
In a similar percentage (1–2%) of fetuses these antibodies will
trigger the inﬂammation of the AV node and the myocardium.
The inﬂamed tissues may then heal with ﬁbrosis which may
cause heart block, endocardial ﬁbroelastosis, and dilated
cardiomyopathy. Heart block, the most common antibody-
related fetal cardiac complication, typically appears between
18 and 24 weeks in fetuses exposed to high anti-Ro antibody
levels (Jaeggi et al., 2010). The rationale to treat isolated fetal
CHB in-utero is primarily to temper the antibody-mediated
myocardial inﬂammation, to augment fetal cardiac output
and to improve survival. Maternal dexamethasone administra-
tion has been shown to improve incomplete fetal AV block,
myocardial dysfunction, and cavity effusions. Beta-sympat-
homimetics such as salbutamol and terbutaline may be used
to increase the fetal heart rate and myocardial contractility.
Published data from the Hospital for Sick Children in Toronto
(Jaeggi et al., 2004) suggest an improved survival above 90%
for antibody-related CHB if maternal high-dose dexametha-
sone was initiated at the time of anomaly diagnosis and was
maintained during the pregnancy and if a b-adrenergic drug
was added at fetal heart rates below 50–55 bpm.
Despite the improvement in outcome, the use of ﬂuorinated
steroids remains debated because a signiﬁcant proportion of
fetuses with immune-mediated CHB will also survive without
anti-inﬂammatory steroid treatment and because the steroids
increases the risk of oligohydramnios, fetal growth restriction,
maternal hypertension and insulin-dependent diabetes. To
minimize the risk of adverse events the treatment guidelines
for immune-mediated heart block at the co-authors center
has been modiﬁed in recent years. Dexamethasone, which is
started at 8 mg/day, is now reduced to 4 mg/day after two
weeks and then to 2 mg/day after 28 gestational weeks in
uncomplicated cases. On the other hand, we do not recom-
mend transplacental treatment for late diagnosis after
32 weeks with asymptomatic isolated fetal CHB and ventricu-
lar rate above 50 bpm. Delivery, usually by caesarian section,
is recommended in a tertiary care facility with expertise in
the postnatal management of cardiac patients.5. Fetal tachycardia
Sinus tachycardia (ST), supraventricular tachycardia (SVT)
and atrial ﬂutter (AF) are the main causes of fetal tachycardia.
Echocardiography is the diagnostic cornerstone in differentiat-
ing these mechanisms and in evaluating the hemodynamic
impact. All forms of persistent tachyarrhythmia may be
Figure 5 Atrial ﬂutter. Simultaneous M-Mode tracing to record
the RV and LA freewall movements during the cardiac cycles. The
atrial rate is very fast and regular at 462 bpm while the ventricular
rate is 231 bpm suggesting 2:1 AV conduction.
Figure 6 SVT with a heart rate of 240 bpm. M-Mode tracing
through the right atrium (bottom) and the right ventricle (top).
There is 1:1 AV-conduction with a short AV-interval.
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the spectrum may lead to heart failure, neurological complica-
tions and death.
Brief sinus tachycardia is a common observation and usu-
ally related to fetal activity. A variety of pregnancy conditions
causes persistent ST such as anemia, fetal hypoxia, infections,
and thyrotoxicosis (Jaeggi et al., 2006). Echocardiographically,
ST resembles the normal cardiac rhythm with the exception
that the atrial and ventricular rates are increased above
180 bpm. The importance of ST is recognizing and treating
the underlying cause.
Atrial ﬂutter (Fig. 5) is sustained by a fast rotating macro-
reentrant circuit that is conﬁned to the atrium. The AV node is
not part of the reentrant circuit. The atrial rate typically ranges
between 300 and 500 bpm which is sufﬁciently fast that only
every second (or third) atrial beat is conducted across the
AV node, resulting in ventricular response rates between 150
and 250 bpm. AF is typically observed in the last trimester
as the propagation of a sustained reentrant circuit depends
on a critical atrial size (Jaeggi et al., 1998b). Management of
AF aims to reverse the arrhythmia to sinus rhythm or other-
wise to slow AV conduction rates thus reducing the ventricular
response rate to a near normal rate. This allows better ventric-
ular ﬁlling and improved cardiac output. Maternal digoxin,
sotalol, ﬂecainide, and amiodarone have all been used to re-
store sinus rhythm (Jaeggi and Tulzer, 2009). After 37 weeks
of gestation, we prefer delivery by caesarian section followed
by postnatal conversion to a normal rhythm e.g. by esophageal
overdrive pacing. Once sinus rhythm has been established after
birth, recurrence of AF is uncommon and no antiarrhythmic
long-term prophylaxis is usually required.Supraventricular tachycardia (SVT) (Fig. 6) is the most com-
mon cause of intermittent and persistent tachyarrhythmia with
AV reentry related to a fast conducting accessory pathway
being by far the most common mechanism. In reentrant
SVT, the electrical circuit typically uses the AV node for the
antegrade (atrio–ventricular) electrical conduction and the
accessory pathway for the retrograde (ventriculo–atrial) con-
duction. As the retrograde pathway conduction is fast, the at-
rium is excited shortly after the ventricle, which yields a short
VA time interval on Doppler or M-mode echocardiography
(so-called short VA SVT). Other features of AV-reentry in-
clude the regular tachycardia rate that may range between
180 and 300 bpm, 1:1 AV relationship and, in intermittent
SVT, the sudden onset and termination of tachycardia.
The following management options are available for fetal
SVT: (a) no treatment; (b) antiarrhythmic drug therapy; and
(c) delivery. Abstention of treatment with close pregnancy
monitoring is a valid option if the fetus presents with intermit-
tent brief runs of tachycardia in the absence of hemodynamic
impairment. More sustained tachyarrhythmia may signiﬁ-
cantly affect the fetal cardiovascular function due to impaired
ventricular ﬁlling, reduced cardiac contractility and venous
congestion. In this situation, rapid and permanent conversion
to sinus rhythm to prevent or resolve congestive heart failure is
a primary task. Experience in fetal SVT treatment exists with a
number of antiarrhythmic agents, including maternally admin-
istered digoxin, ﬂecainide, sotalol and amiodarone and, in life-
threatening situations, with the direct fetal administration of
adenosine, digoxin and/or amiodarone e.g. into the umbilical
vein (Jaeggi and Tulzer, 2009). If a fetus presents with signiﬁ-
cant SVT after 35–37 weeks of gestation, expedited delivery
followed by postnatal conversion becomes a ﬁrst choice op-
tion. At an earlier gestational age, the risks associated with
premature delivery probably outweigh the potential hazards
of fetal–maternal pharmacological treatment.
66 R. Weber et al.In summary, by means of echocardiography, it is possible
to accurately diagnose fetal arrhythmia mechanisms, to assess
the hemodynamic consequences and to conclude on the need
of prenatal care. If indicated, efﬁcient treatment is available
to control SVT and AF, the most common causes for
intermittent and persistent tachyarrhythmias above 200 bpm.
The outcome of isolated fetal CHB may be improved by trans-
placental treatment with dexamethasone and b-stimulation at
heart rates of 50–55 bpm.
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